Table 3.
PITX1 | |||||
---|---|---|---|---|---|
Parameter | n Evaluable | Negative (%) | Low (%) | High (%) | p Value |
All cancers | 15,011 | 38.3 | 57.7 | 4.0 | |
Tumor stage | <0.0001 | ||||
pT2 | 9555 | 41.5 | 55.5 | 3.0 | |
pT3a | 3366 | 34.6 | 60.4 | 5.0 | |
pT3b-pT4 | 2030 | 30.0 | 63.0 | 7.0 | |
Gleason grade | <0.0001 | ||||
≤3 + 3 | 2794 | 41.8 | 55.3 | 2.8 | |
3 + 4 | 7971 | 40.2 | 56.5 | 3.3 | |
3 + 4 Tert.5 | 720 | 38.9 | 57.6 | 3.5 | |
4 + 3 | 1479 | 30.6 | 62.8 | 6.6 | |
4 + 3 Tert.5 | 1056 | 31.3 | 63.5 | 5.2 | |
≥4 + 4 | 867 | 28.7 | 61.5 | 9.8 | |
Lymph node metastasis | <0.0001 | ||||
N0 | 9067 | 37.7 | 58.0 | 4.3 | |
N+ | 1121 | 30.2 | 63.2 | 6.6 | |
Surgical margin | <0.0001 | ||||
negative | 11,973 | 39.2 | 57.1 | 3.7 | |
positive | 2985 | 35.1 | 59.8 | 5.1 |